These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26450668)

  • 1. Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles.
    Nie S; Zhang J; Martinez-Zaguilan R; Sennoune S; Hossen MN; Lichtenstein AH; Cao J; Meyerrose GE; Paone R; Soontrapa S; Fan Z; Wang S
    J Control Release; 2015 Dec; 220(Pt A):61-70. PubMed ID: 26450668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles target intimal macrophages in atherosclerotic lesions.
    Dhanasekara CS; Zhang J; Nie S; Li G; Fan Z; Wang S
    Nanomedicine; 2021 Feb; 32():102346. PubMed ID: 33259961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-atherogenic effects of CD36-targeted epigallocatechin gallate-loaded nanoparticles.
    Zhang J; Nie S; Zu Y; Abbasi M; Cao J; Li C; Wu D; Labib S; Brackee G; Shen CL; Wang S
    J Control Release; 2019 Jun; 303():263-273. PubMed ID: 30999008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles.
    Zhang J; Nie S; Martinez-Zaguilan R; Sennoune SR; Wang S
    J Nutr Biochem; 2016 Apr; 30():14-23. PubMed ID: 27012617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
    Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
    Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary homocysteine promotes atherosclerosis in apoE-deficient mice by inducing scavenger receptors expression.
    Thampi P; Stewart BW; Joseph L; Melnyk SB; Hennings LJ; Nagarajan S
    Atherosclerosis; 2008 Apr; 197(2):620-9. PubMed ID: 17950295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD36 and macrophages in atherosclerosis.
    Collot-Teixeira S; Martin J; McDermott-Roe C; Poston R; McGregor JL
    Cardiovasc Res; 2007 Aug; 75(3):468-77. PubMed ID: 17442283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.
    Moore KJ; Kunjathoor VV; Koehn SL; Manning JJ; Tseng AA; Silver JM; McKee M; Freeman MW
    J Clin Invest; 2005 Aug; 115(8):2192-201. PubMed ID: 16075060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.
    Tang FT; Cao Y; Wang TQ; Wang LJ; Guo J; Zhou XS; Xu SW; Liu WH; Liu PQ; Huang HQ
    Eur J Pharmacol; 2011 Jan; 650(1):275-84. PubMed ID: 20854809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation.
    Harb D; Bujold K; Febbraio M; Sirois MG; Ong H; Marleau S
    Cardiovasc Res; 2009 Jul; 83(1):42-51. PubMed ID: 19264766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
    Dai XY; Cai Y; Sun W; Ding Y; Wang W; Kong W; Tang C; Zhu Y; Xu MJ; Wang X
    Cardiovasc Res; 2014 Feb; 101(2):297-305. PubMed ID: 24253523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aged garlic extract inhibits homocysteine-induced scavenger receptor CD36 expression and oxidized low-density lipoprotein cholesterol uptake in human macrophages in vitro.
    Morihara N; Ide N; Weiss N
    J Ethnopharmacol; 2011 Apr; 134(3):711-6. PubMed ID: 21256950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human scavenger protein AIM increases foam cell formation and CD36-mediated oxLDL uptake.
    Amézaga N; Sanjurjo L; Julve J; Aran G; Pérez-Cabezas B; Bastos-Amador P; Armengol C; Vilella R; Escolà-Gil JC; Blanco-Vaca F; Borràs FE; Valledor AF; Sarrias MR
    J Leukoc Biol; 2014 Mar; 95(3):509-20. PubMed ID: 24295828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages.
    Lian TW; Wang L; Lo YH; Huang IJ; Wu MJ
    Biochim Biophys Acta; 2008 Oct; 1781(10):601-9. PubMed ID: 18662803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.
    Febbraio M; Podrez EA; Smith JD; Hajjar DP; Hazen SL; Hoff HF; Sharma K; Silverstein RL
    J Clin Invest; 2000 Apr; 105(8):1049-56. PubMed ID: 10772649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4.
    Kiyan Y; Tkachuk S; Hilfiker-Kleiner D; Haller H; Fuhrman B; Dumler I
    J Mol Cell Cardiol; 2014 Jan; 66():72-82. PubMed ID: 24239845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation.
    Rahaman SO; Lennon DJ; Febbraio M; Podrez EA; Hazen SL; Silverstein RL
    Cell Metab; 2006 Sep; 4(3):211-21. PubMed ID: 16950138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD36 is a receptor for oxidized low density lipoprotein.
    Endemann G; Stanton LW; Madden KS; Bryant CM; White RT; Protter AA
    J Biol Chem; 1993 Jun; 268(16):11811-6. PubMed ID: 7685021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squalene ameliorates atherosclerotic lesions through the reduction of CD36 scavenger receptor expression in macrophages.
    Granados-Principal S; Quiles JL; Ramirez-Tortosa CL; Ochoa-Herrera J; Perez-Lopez P; Pulido-Moran M; Ramirez-Tortosa MC
    Mol Nutr Food Res; 2012 May; 56(5):733-40. PubMed ID: 22648620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD36 is a receptor for oxidized high density lipoprotein: implications for the development of atherosclerosis.
    Thorne RF; Mhaidat NM; Ralston KJ; Burns GF
    FEBS Lett; 2007 Mar; 581(6):1227-32. PubMed ID: 17346709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.